Texas Diabetes and Endocrinology

The trials here

What the 11 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes9 trials
• Type 1 diabetes5 trials
• Obesity2 trials
• Coronary artery disease1 trial

Phase

• Phase 33 trials

Status

• Completed6 trials
• Recruiting3 trials
• Active, not recruiting1 trial
• Withdrawn1 trial

Lead sponsor

• Medtronic MiniMed, Inc.3 trials
• Boehringer Ingelheim2 trials
• Insulet Corporation2 trials
• Senseonics, Inc.2 trials
• Amgen1 trial
• and 1 more

Running trials

• Recruiting

  Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes

  NCT07864168· Medtronic MiniMed, Inc.· Source

  Contact: Emmanuel Lopez

• Recruiting

  Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes

  NCT07521475· Insulet Corporation· Source

  Contact: Jennifer Perez

• Recruiting

  OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

  NCT07136012· Phase 3· Amgen· Source

• Active, not recruiting

  Eversense® Non-adjunctive Use Post Approval Study

  NCT04836546· Senseonics, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Type 2 diabetes2 recruiting
• Coronary artery disease1 recruiting
• Type 1 diabetes1 recruiting

Closed trials

• Withdrawn

  SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients With Type 1 and Type 2 Diabetes

  NCT06719531· Medtronic MiniMed, Inc.· Source

• Completed

  Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes

  NCT06273124· Tandem Diabetes Care, Inc.· Source

• Completed

  A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight

  NCT06066528· Phase 3· Boehringer Ingelheim· Source

• Completed

  A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight

  NCT06066515· Phase 3· Boehringer Ingelheim· Source

• Completed

  OP5-005 Using Omnipod 5 in Adults With Type 2

  NCT05815342· Insulet Corporation· Source

• Completed

  In-Home Study With MiniMed™ 780G Pump Automated Control in Type 2-Evaluation of the AHCL System in Adults With Insulin-requiring Type 2 Diabetes

  NCT05238142· Medtronic MiniMed, Inc.· Source

• Completed

  Post Approval Study of the Eversense® Continuous Glucose Monitoring

  NCT03908125· Senseonics, Inc.· Source